Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
To determine whether higher as compared with lower maintenance doses of clopidogrel can
adequately improve the degree of platelet inhibition in carriers of a reduced-function
CYP2C19 allele.